Public Policy and Advocacy
When Elizabeth Glaser discovered that the drugs prolonging her own life were unavailable to her daughter, she became the first person to champion the needs of children with HIV/AIDS before Congress and the White House.
Building on Elizabeth’s legacy, EGPAF now works with policymakers in the U.S. and around the world to continue the work Elizabeth started, advocating for the best public policies for women, children, and families with HIV/AIDS.
Public Policy and Advocacy in the U.S.
In the United States our public policy and advocacy team works with key U.S. policy makers in Congress and the Administration to ensure that the needs of pregnant women and children with HIV are addressed both at home and around the globe. We specifically focus on programs such as the Ryan White CARE ACT as well as the President’s Emergency Plan for AIDS Relief (PEPFAR) and other foreign assistance programming Additionally, HIV/AIDS research and pediatric drug development remain key priorities for EGPAF. In order to eliminate pediatric AIDS, research in both medical science and public health practice must be conducted to increase the effectiveness of HIV care and treatment and prevention of mother-to-child transmission (PMTCT) programs on the ground.
Regional Advocacy in Africa
Our team based in Africa works directly with intergovernmental organizations like the African Union, the East African Community and the Southern African Development Community (SADC) to ensure that the elimination of pediatric HIV, and other relevant issues are prioritized. They have established themselves as a resource for policy makers and key opinion leaders in areas with a high burden of HIV. The advocacy team is also focused on ensuring that there is political momentum and leadership to achieve elimination of pediatric AIDS by working with Ministers of Health, Parliamentarians and Heads of States.
EGPAF engages with multiple stakeholders, including international organizations, UN agencies, and international NGO’s, from its office in Geneva, Switzerland. Our advocacy work focuses on ensuring that that needs of women and children affected by HIV are taken into account at all levels in international health diplomacy negotiations. For example, we recently reacted to a report from the Human Rights Council of the UN stressing the importance of pediatric treatment of HIV—read more here.
- 90-90-90 targets for HIV-positive children
- What’s next in ending pediatric AIDS? June 2014 Meeting Report
- Increasing Children’s Access to HIV Treatment - EGPAF/Inter-Parliamentarian Union Brief
- Innovation Needed on Pediatric ARV Formulations
- Frontline Healthcare Workers: Integral to the Continuum of Care of PMTCT
- Pediatric HIV Treatment Must Be A Global Priority
- Why Children Matter in the Fight Against HIV